switching from semaglutide to tirzepatide dose conversion Switching from tirzepatide to semaglutide

These telehealth providers are integrated with NovoCare

The most important first step is to ensure you are a proper candidate in a consultation with a qualified injector

These findings indicate that: Members in Omadas Enhanced GLP-1 Care Track showed higher average medication persistence rates through 24 weeks compared to other real-world evidence Those who persisted saw an average of 11% weight loss with semaglutide and 13% with tirzepatide, outcomes similar to what has been shown in clinical trials Providing the right kind of support to enable people to persist with their GLP-1 medication use long enough to see benefits can help them achieve clinical trial-level weight loss, setting the stage for cardiometabolic disease risk reduction

Davis EM, Sandoval DA

Jensen ME, Klausen MK, Bergmann ML, Knudsen GM, Vilsbll T, Stove C, et al

Rotating within this area helps avoid skin problems like irritation or lumps, which can occur if the same spot is used repeatedly